MetaVia Inc.
NASDAQMTVA heads into its May 22 earnings report on one of the most dramatic short-term rallies in its peer group — and the borrow market tells a contradictory story. The price move commands attention first. The stock closed at $1.88 on May 19, up 69% in a single session and nearly 94% on the week. That kind of acceleration in a micro-cap biotech ahead of a scheduled print is rarely…
MTVA short interest explodes 1,030% in one week to 0.27% of float, as cost to borrow surges to 217% APR.
MTVA heads into its May 22 earnings report on one of the most dramatic short-term rallies in its peer group — and the borrow market tells a contradictory story. The price move commands attention first. The stock closed…
MTVA heads into its May 18 earnings print carrying one of the most expensive borrow costs in the biotech universe — a signal that short-side pressure, while not dominant by position size, is punishingly costly to…
Snapshot as of 29 Jun 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MTVA — free to start on ORTEX.
Sign up for free →Open MTVA on ORTEX